TEVA-MAPROTILINE 50 MG
MAPROTILINE HYDROCHLORIDE : 50 MG · DIN 02158620 · TEVA CANADA LIMITED
Health Canada status: CANCELLED POST MARKET
What is TEVA-MAPROTILINE?
TEVA-MAPROTILINE 50 MG contains MAPROTILINE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02158620, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Apr-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02158620 |
|---|---|
| Brand name | TEVA-MAPROTILINE |
| Generic / active ingredient | MAPROTILINE HYDROCHLORIDE : 50 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AA21 MAPROTILINE |
| AHFS class | 28:16.04.28 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Apr-2018 |
| Original market date | 1995-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N06AA21 MAPROTILINE. 0 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LUDIOMIL TAB 10MG | 10 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00641855 |
| LUDIOMIL TAB 25MG | 25 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00360481 |
| LUDIOMIL TAB 50MG | 50 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00360503 |
| LUDIOMIL TAB 75MG | 75 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00360511 |
| NOVO-MAPROTILINE - TAB 10MG | 10 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02158604 |
| PMS-MAPROTILINE | 10 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231559 |
| PMS-MAPROTILINE | 25 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231560 |
| PMS-MAPROTILINE | 50 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231561 |
| PMS-MAPROTILINE | 75 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | DIN 02231562 |
| TEVA-MAPROTILINE | 25 MG | TABLET | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02158612 |
Who else supplies MAPROTILINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MAPROTILINE appears in 8 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.